Akebia Therapeutics, Inc.
AKBA
$1.44
$0.021.41%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 256.36% | 389.27% | 247.62% | 170.19% | 20.84% |
| Total Receivables | 36.85% | 105.85% | 144.61% | 131.17% | -12.53% |
| Inventory | -3.90% | -9.03% | -30.01% | -22.72% | 3.52% |
| Prepaid Expenses | -- | -- | -- | -91.29% | -72.19% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -25.28% | 13.12% | 6.86% | 64.49% | 27.23% |
| Total Current Assets | 122.22% | 158.03% | 109.33% | 80.43% | -3.65% |
|
|
|||||
| Total Current Assets | 122.22% | 158.03% | 109.33% | 80.43% | -3.65% |
| Net Property, Plant & Equipment | -53.11% | -46.67% | -41.90% | -38.50% | -35.07% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 59.67% | 49.12% | 148.57% | 225.12% | 200.87% |
| Total Assets | 70.65% | 75.80% | 56.95% | 37.57% | -8.70% |
|
|
|||||
| Total Accounts Payable | 39.56% | -25.25% | 14.32% | 6.53% | 3.72% |
| Total Accrued Expenses | 176.91% | 170.44% | 117.17% | 48.62% | -22.52% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 132.35% | 166.76% | 147.46% | 91.83% | -59.59% |
| Total Finance Division Other Current Liabilities | 18.93% | 63.66% | -51.85% | 21.48% | 24.61% |
| Total Other Current Liabilities | 18.93% | 63.66% | -51.85% | 21.48% | 24.61% |
| Total Current Liabilities | 101.37% | 102.98% | 10.64% | 37.21% | -18.98% |
|
|
|||||
| Total Current Liabilities | 101.37% | 102.98% | 10.64% | 37.21% | -18.98% |
| Long-Term Debt | 0.42% | 97.21% | 94.69% | 115.10% | 57.67% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -89.35% | -72.20% | -60.36% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -51.61% | -89.35% | -60.27% | -87.01% | -80.98% |
| Total Liabilities | 27.46% | 25.24% | 24.58% | 13.01% | -0.89% |
|
|
|||||
| Common Stock & APIC | 5.35% | 6.72% | 6.21% | 6.07% | 3.22% |
| Retained Earnings | -0.32% | -0.96% | -2.23% | -2.79% | -4.31% |
| Treasury Stock & Other | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Common Equity | 166.30% | 182.52% | 186.58% | 190.18% | -60.82% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 166.30% | 182.52% | 186.58% | 190.18% | -60.82% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 166.30% | 182.52% | 186.58% | 190.18% | -60.82% |
|
|
|||||